International patterns of childhood chronic myeloid leukemia: comparisons between the United States and resource-restricted nations.

@article{Sadak2014InternationalPO,
  title={International patterns of childhood chronic myeloid leukemia: comparisons between the United States and resource-restricted nations.},
  author={Karim Thomas Sadak and Kara Fultz and Adam Mendizabal and Gregory Reaman and Pat Garcia-Gonzalez and Paul H. Levine},
  journal={Pediatric blood & cancer},
  year={2014},
  volume={61 10},
  pages={1774-8}
}
BACKGROUND Chronic myeloid leukemia (CML) is a rare disease in children and represents approximately 2% of all childhood leukemia. This results in difficulty creating large cohorts of patients for pediatric CML research. The Glivec International Patient Assistance Program (GIPAP) is a patient-access program sponsored by Novartis Oncology and administered by The Max Foundation (MAX) that provides imatinib free of charge to patients in resource-restricted countries who are not able to afford this… CONTINUE READING